List of Excipients in API amlodipine and atorvastatin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing amlodipine and atorvastatin
Excipients in ANDA-approved (generic) drugs containing amlodipine and atorvastatin
Detailed excipient profiles for amlodipine and atorvastatin
Excipient focus: ARGININE
amlodipine and atorvastatin drug variants containing ARGININE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4510 |
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4513 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing ARGININE
Excipient focus: CALCIUM ACETATE
amlodipine and atorvastatin drug variants containing CALCIUM ACETATE
amlodipine and atorvastatin drug variants not containing CALCIUM ACETATE
Excipient focus: CALCIUM CARBONATE
amlodipine and atorvastatin drug variants containing CALCIUM CARBONATE
amlodipine and atorvastatin drug variants not containing CALCIUM CARBONATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine and atorvastatin drug variants containing CELLULOSE, MICROCRYSTALLINE
amlodipine and atorvastatin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
amlodipine and atorvastatin drug variants containing CROSCARMELLOSE SODIUM
amlodipine and atorvastatin drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
amlodipine and atorvastatin drug variants containing FD&C BLUE NO. 2
amlodipine and atorvastatin drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE YELLOW
amlodipine and atorvastatin drug variants containing FERRIC OXIDE YELLOW
amlodipine and atorvastatin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
amlodipine and atorvastatin drug variants containing HYDROXYPROPYL CELLULOSE
amlodipine and atorvastatin drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSES
amlodipine and atorvastatin drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | amlodipine and atorvastatin | 68382-434 |
| Zydus Lifesciences Limited | amlodipine and atorvastatin | 70771-1467 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing HYPROMELLOSES
Excipient focus: LECITHIN, SOYBEAN
amlodipine and atorvastatin drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4510 |
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4513 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
amlodipine and atorvastatin drug variants containing MAGNESIUM STEARATE
amlodipine and atorvastatin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
amlodipine and atorvastatin drug variants containing POLYETHYLENE GLYCOL
amlodipine and atorvastatin drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3000
amlodipine and atorvastatin drug variants containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | amlodipine and atorvastatin | 46708-755 |
| Alembic Pharmaceuticals Inc | amlodipine and atorvastatin | 62332-755 |
| Prasco Laboratories | amlodipine and atorvastatin | 66993-263 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing POLYETHYLENE GLYCOL 3000
Excipient focus: POLYSORBATE 80
amlodipine and atorvastatin drug variants containing POLYSORBATE 80
amlodipine and atorvastatin drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
amlodipine and atorvastatin drug variants containing POLYVINYL ALCOHOL
amlodipine and atorvastatin drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | amlodipine and atorvastatin | 68382-434 |
| Zydus Lifesciences Limited | amlodipine and atorvastatin | 70771-1467 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
amlodipine and atorvastatin drug variants containing SILICON DIOXIDE
amlodipine and atorvastatin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CARBONATE
amlodipine and atorvastatin drug variants containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4510 |
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4513 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing SODIUM CARBONATE
Excipient focus: STARCH, CORN
amlodipine and atorvastatin drug variants containing STARCH, CORN
amlodipine and atorvastatin drug variants not containing STARCH, CORN
Excipient focus: TALC
amlodipine and atorvastatin drug variants containing TALC
amlodipine and atorvastatin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
amlodipine and atorvastatin drug variants containing TITANIUM DIOXIDE
amlodipine and atorvastatin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
amlodipine and atorvastatin drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Prasco Laboratories | amlodipine and atorvastatin | 66993-263 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing WATER
Excipient focus: XANTHAN GUM
amlodipine and atorvastatin drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4510 |
| Mylan Pharmaceuticals Inc | amlodipine and atorvastatin | 0378-4513 |
| >Company | >Ingredient | >NDC |
amlodipine and atorvastatin drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links